Bio
Gennao Bio Presents New Data on Novel Gene Monoclonal Antibody Platform Technology at the American Association for Cancer Research (AACR) 2021 Annual Meeting
~ Preclinical data show the utility of Gennao’s proprietary first-in-class monoclonal antibody 3E10-D31N (GMABD31N), a cell penetrating antibody, to non-covalently bind to and systemically deliver therapeutic levels of multiple types of nucleic acid payloads to cells in vitro and tumors in vivo ~ ~ GMABD31N combined with a RIG-I ligand 3pRNA (GMABD31N/3pRNA) efficiently targets and …
Breaking News: AnPac Bio Announces Preliminary Results From Prospective Trials Indicating Early-Stage Cancer Screening Effectiveness
AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today preliminary results from two prospective studies demonstrated that AnPac Bio’s Cancer Differentiation Analysis (CDA) based tests have the ability to assess the risks of cancer occurrence. In a …
Manus Bio and STK Bio-Ag Technologies announce partnership to develop and commercialize pipeline of next-generation biopesticides
Manus Bio Manus Bio’s Augusta, GA Manufacturing Facility CAMBRIDGE, Mass. and PETACH TIKVAH, Israel, July 28, 2020 (GLOBE NEWSWIRE) — Manus Bio Inc. (Manus Bio), a leader in the production of complex natural products through advanced bio-fermentation, and STK Bio-Ag Technologies (STK), an innovator of botanical and ‘hybrid’ crop protection solutions, are announcing a collaboration …
Most Strategic Ways Companies Follow to Grow in the Bio Process Technology Market
Bio-Process Technology Market Research Report 2020, Size, Growth, Trends, Share and Industry Analysis by Type (flow cytometry, cell culture, cell expansion, cell line development, virus infiltration), by Application (biopharmaceuticals, specialty products and industrial chemicals, environmental management aid), by End Users (hospitals, research Centers, medical institutions) – Global Forecast to 2022 Bio process Technology Market overview Bio-process …
Solid Bio starts to break up as the ax swings down on one-third of workers, CMO
Amid clinical holds, manufacturing concerns, safety issues and downsized IPOs, Solid Biosciences is bloodletting from its staffers. First, the history: Toward the end of last year, a new clinical hold following serious adverse events formed just part of a long line of setbacks for Solid Bio and the development of its gene therapy for Duchenne …
Key Players are A&D, Bayer CropScience, Elementis, Evonik, Marrone Bio Innovations, Syngenta and Thermo fisher Scientific
DUBLIN, Nov. 6, 2019 /PRNewswire/ — The “Rheology: Technologies, Opportunities and Global Markets” report has been added to ResearchAndMarkets.com’s offering. The scope of this report is broad and covers global markets for rheology technology in various types of end-use industry applications. The market is broken down by product type, sample type, end-use industry and region. …
Bio Identical Hormone Replacement Therapy – Yes or No?
• What is Hormone Pellet Therapy? Pellet treatment utilizes hormones determined to recreate the body’s ordinary hormonal levels. Patients have discovered that bio-indistinguishable hormone supplanting treatment with pellet inserts is greatly successful. Inserts, put under the skin, reliably discharge little, physiologic measurements of hormones that give ideal treatment. Dissimilar to oral and transdermal types of …